These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1611520)

  • 21. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
    Jones DA; Sawyer WH
    J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference between male and female rats in vasopressor response to arginine vasopressin.
    László FA; Varga C; Papp A; Pávó I; Fahrenholz F
    Acta Physiol Hung; 1993; 81(2):137-45. PubMed ID: 8197870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A V1 vasopressin receptor antagonist has nonspecific neurodepressant actions in the spinal cord.
    Porter JP; Brody MJ
    Neuroendocrinology; 1986; 43(1):75-8. PubMed ID: 3012394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the influence of vasopressin neuropeptides on social recognition of rats.
    Sekiguchi R; Wolterink G; van Ree JM
    Eur Neuropsychopharmacol; 1991 May; 1(2):123-6. PubMed ID: 1821701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
    László FA; Laczi F; Janáky T; Baláspiri L
    Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal flutamide treatment eliminates the adult male rat's dependency upon vasopressin when forming social-olfactory memories.
    Axelson JF; Smith M; Duarte M
    Horm Behav; 1999 Oct; 36(2):109-18. PubMed ID: 10506535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs.
    Liard JF; Dériaz O; Schelling P; Thibonnier M
    Am J Physiol; 1982 Nov; 243(5):H663-9. PubMed ID: 7137358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells.
    Wuthrich RP; Vallotton MB
    Am J Physiol; 1986 Sep; 251(3 Pt 2):F499-505. PubMed ID: 3019160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous vasopressin, innate anxiety, and the emission of pro-social 50-kHz ultrasonic vocalizations during social play behavior in juvenile rats.
    Lukas M; Wöhr M
    Psychoneuroendocrinology; 2015 Jun; 56():35-44. PubMed ID: 25800147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin and vasopressin-antagonists applied to neonatal Wistar rats: effects on body and brain development and water metabolism.
    Snijdewint FG; Boer GJ
    Neurobehav Toxicol Teratol; 1986; 8(3):213-7. PubMed ID: 3736748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Septal vasopressin induced preservation of social recognition in rats was abolished by pinealectomy.
    Appenrodt E; Juszczak M; Schwarzberg H
    Behav Brain Res; 2002 Aug; 134(1-2):67-73. PubMed ID: 12191793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors.
    Kasson BG; Hsueh AJ
    Endocrinology; 1986 Jan; 118(1):23-31. PubMed ID: 3000735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin infusion into the lateral septum of adult male rats rescues progesterone-induced impairment in social recognition.
    Bychowski ME; Mena JD; Auger CJ
    Neuroscience; 2013 Aug; 246():52-8. PubMed ID: 23639881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
    László FA; Baláspiri L
    Acta Med Hung; 1986; 43(3):333-9. PubMed ID: 3588172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.